Palo Alto Investors LP Long-Term Concentrated

CIK: 0001306923 · Show all filings

Period: Q1 2014 (← Previous) (Next →)

Filing Date: May 16, 2014

Total Value ($000): $1,210,103

Holdings (39)

INTERMUNE INC 12.2%
Value ($000) $147,893 Shares 4,418,662 Est. Cost $15.49 Unrealized
AUXILIUM PHARMACEUTICALS INC 10.9%
Value ($000) $131,606 Shares 4,842,031 Est. Cost $17.45 Unrealized
CYBERONICS INC 9.2%
Value ($000) $111,701 Shares 1,711,730 Est. Cost $52.15 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 8.6%
Value ($000) $103,530 Shares 1,101,028 Est. Cost $66.46 Unrealized +53.9%
CUBIST PHARMACEUTICALS INC 8.3%
Value ($000) $100,158 Shares 1,369,211 Est. Cost $56.60 Unrealized
QUESTCOR PHARMACEUTICALS INC 5.2%
Value ($000) $62,949 Shares 969,495 Est. Cost $48.32 Unrealized
ABIOMED INC 4.7%
Value ($000) $57,348 Shares 2,202,289 Est. Cost $21.31 Unrealized
VNDA VANDA PHARMACEUTICALS INC 4.3%
Value ($000) $52,251 Shares 3,215,424 Est. Cost $7.72 Unrealized +84.2%
BMRN BIOMARIN PHARMACEUTICAL INC 4.2%
Value ($000) $50,863 Shares 745,687 Est. Cost $63.65 Unrealized +15.8%
STAA STAAR SURGICAL CO 4.0%
Value ($000) $48,761 Shares 2,593,653 Est. Cost $8.10 Unrealized +99.0%
KYTHERA BIOPHARMACEUTICALS I 3.0%
Value ($000) $35,993 Shares 905,259 Est. Cost $38.50 Unrealized
ANACOR PHARMACEUTICALS INC 2.6%
Value ($000) $31,457 Shares 1,572,078 Est. Cost $5.59 Unrealized
AMAG PHARMACEUTICALS INC 2.6%
Value ($000) $31,241 Shares 1,614,536 Est. Cost $22.29 Unrealized
ALIMERA SCIENCES INC 2.4%
Value ($000) $28,680 Shares 3,634,984 Est. Cost $4.88 Unrealized
ARIAD PHARMACEUTICALS INC 2.3%
Value ($000) $27,877 Shares 3,458,624 Est. Cost $6.82 Unrealized
SEQUENOM INC 2.0%
Value ($000) $23,982 Shares 9,788,442 Est. Cost $3.91 Unrealized
PRTA PROTHENA CORP PLC 1.7%
Value ($000) $20,416 Shares 532,918 Est. Cost $22.48 Unrealized +43.4%
RIGEL PHARMACEUTICALS INC 1.7%
Value ($000) $20,057 Shares 5,169,301 Est. Cost $3.43 Unrealized
CELLADON CORP 1.5%
Value ($000) $17,779 Shares 1,491,500 Est. Cost $11.92 Unrealized
MOMENTA PHARMACEUTICALS INC 1.3%
Value ($000) $15,319 Shares 1,314,976 Est. Cost $14.69 Unrealized
NPS PHARMACEUTICALS INC 1.1%
Value ($000) $13,026 Shares 435,200 Est. Cost $30.36 Unrealized
CLOVIS ONCOLOGY INC 1.1%
Value ($000) $12,947 Shares 186,900 Est. Cost $60.27 Unrealized
QLT INC 0.9%
Value ($000) $11,348 Shares 2,041,043 Est. Cost $4.40 Unrealized
EXAS EXACT SCIENCES CORP 0.9%
Value ($000) $11,020 Shares 777,676 Est. Cost $12.83 Unrealized +5.3%
OREXIGEN THERAPEUTICS INC 0.9%
Value ($000) $10,849 Shares 1,669,024 Est. Cost $6.50 Unrealized
FOLD AMICUS THERAPEUTICS INC 0.7%
Value ($000) $8,221 Shares 3,971,576 Est. Cost $3.07 Unrealized -18.6%
INSM INSMED INC 0.5%
Value ($000) $6,030 Shares 316,699 Est. Cost $11.32 Unrealized +67.9%
SPECTRUM PHARMACEUTICALS INC 0.3%
Value ($000) $3,154 Shares 402,285 Est. Cost $7.48 Unrealized
REVANCE THERAPEUTICS INC 0.2%
Value ($000) $2,888 Shares 91,669 Est. Cost $31.50 Unrealized
CYTK CYTOKINETICS INC 0.2%
Value ($000) $2,348 Shares 247,186 Est. Cost $6.71 Unrealized +34.7%
AVEO PHARMACEUTICALS INC 0.2%
Value ($000) $2,137 Shares 1,429,174 Est. Cost $2.50 Unrealized
HYPERION THERAPEUTICS INC 0.1%
Value ($000) $1,618 Shares 62,700 Est. Cost $22.00 Unrealized
XOMA CORP DEL 0.1%
Value ($000) $1,334 Shares 256,100 Est. Cost $3.63 Unrealized
GERN GERON CORP 0.1%
Value ($000) $1,060 Shares 507,300 Est. Cost $3.99 Unrealized 0.0%
SOPHIRIS BIO INC 0.1%
Value ($000) $975 Shares 292,900 Est. Cost $3.88 Unrealized
ALGN ALIGN TECHNOLOGY INC 0.0%
Value ($000) $403 Shares 7,788 Est. Cost $55.98 Unrealized 0.0%
CELGENE CORP 0.0%
Value ($000) $362 Shares 2,590 Est. Cost $159.15 Unrealized
SHIRE PLC 0.0%
Value ($000) $267 Shares 1,800 Est. Cost $148.33 Unrealized
GILD GILEAD SCIENCES INC 0.0%
Value ($000) $255 Shares 3,600 Est. Cost $54.49 Unrealized 0.0%